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Summary
Lipid droplets (LDs) are ubiquitous but poorly under-
stood neutral-lipid-rich eukaryotic organelles that
may participate in functions as diverse as lipid homeo-
stasis, membrane traffic, and signaling [1]. We report
that infection with the obligate intracellular pathogen
Chlamydia trachomatis, the causative agent of tra-
choma and many sexually transmitted diseases [2],
leads to the accumulation of neutral-lipid-rich struc-
tures with features of LDs at the cytoplasmic surface
of the bacteria-containing vacuole. To identify bacte-
rial factors that target these organelles, we screened
a collection of yeast strains expressing GFP-tagged
chlamydial ORFs and identified several proteins with
tropism for eukaryotic LDs. We determined that three
of these LD-associated (Lda) proteins are translocated
into the mammalian host and associate with neutral-
lipid-rich structures. Furthermore, the stability of
one Lda protein is dependent on binding to LDs, and
pharmacological inhibition of LD formation negatively
impacted chlamydial replication. These results sug-
gest that C. trachomatis targets LDs to enhance its
survival and replication in infected cells. The co-option
of mammalian LD function by a pathogenic bacterium
represents a novel mechanism of eukaryotic organelle
subversion and provides unique research opportuni-
ties to explore the function of these understudied
organelles.
Results and Discussion
C. trachomatis replicates within a membrane bound
vacuole (termed the ‘‘inclusion’’) that is inaccessible
to endocytic traffic or secretory glycoproteins and is
devoid of most known endosomal, lysosomal, or Golgi
markers [3]. Despite the apparent dissociation of the
inclusion from classical vesicle-mediated membrane
transport, acquisition of host-derived lipids through
vesicle-mediated and non-vesicle-mediated pathways
is essential for C. trachomatis replication [4, 5].
Our understanding of how C. trachomatis co-opts
lipid transport has been limited by its intractability to ge-
netic manipulation and by the abundance of Chlamydia-
specific proteins with no known functional homologs [6].
We reasoned that because the Chlamydiaceae have
*Correspondence: valdi001@mc.duke.eduparasitized eukaryotic cells since early in evolution [7],
lipid transport pathways targeted by C. trachomatis
virulence factors would be conserved in the yeast Sac-
charomyces cerevisiae. Indeed, we recently identified
a cytotoxic chlamydial ORF (CT163) that displayed
strong tropism for yeast lipid droplets (LDs) [8]. LDs
are endoplasmic reticulum (ER)-derived lipid storage
organelles consisting of a hydrophobic core of neutral
lipids (sterol esters and triacylglycerides) surrounded
by a phospholipid monolayer [1]. Because C. trachoma-
tis must acquire host-derived lipids for intracellular
growth, we examined the interaction betweenC. tracho-
matis and mammalian LDs.
LDs and Neutral-Lipid-Rich Structures Accumulate
at the Chlamydial Inclusion
To monitor the subcellular localization of LDs, we
stained C. trachomatis-infected cells with the neutral-
lipid-specific fluorescent dyes BODIPY493/503 and
Nile red. Both dyes labeled LDs scattered in the cyto-
plasm of mammalian cells and a hazy, neutral-lipid-
rich network of tubules and small droplets enveloping
the chlamydial inclusion (Figures 1A and 1B and data
not shown). Because these structures were morpholog-
ically distinct from larger classical LDs observed in
adipocytes or lipid-loaded cells, we hypothesized that
the neutral-lipid-rich structures surrounding the inclu-
sion consisted primarily of small LDs or intermediates
in LD formation. Consistent with this, the inclusions
were enveloped by prominent lipid-rich coats upon oleic
acid treatment (Figure S1 in the Supplemental Data
available with this article online). Interestingly, BOD-
IPY493/503 also stained bacterial membranes (Figures
1B and 1C and Figure S2), suggesting that C. trachoma-
tis may acquire neutral lipids directly from LDs.
To determine if the neutral-lipid-rich structures envel-
oping the inclusion constituted LDs, we monitored the
localization of host LD-associated proteins. HeLa cells
were infected with C. trachomatis and transfected with
EGFP-tagged forms of LD-associated proteins, includ-
ing two members of the PAT family of LD-associated pro-
teins, Adipocyte-Differentiation-Related Protein (ADRP)
and perilipin [9], the triacylglyceride lipase ATGL [10],
and the GTPase Rab18 [11]. Upon treatment with oleic
acid, these markers localized to classical LDs (Fig-
ure S3). In addition, LD markers labeled reticular struc-
tures (perilipin and Rab18) and hazy structures (ATGL
and ADRP) at the periphery of the inclusion (Figure 1D
and Figure S3). However, all LD markers localized to
structures adjacent to but distinct from the inclusion
membrane (IM), indicating that the IM does not mimic
LD membranes (Figure S3).
Given the role of LDs in lipid storage, we hypothesized
that C. trachomatis may exploit these organelles as
a source of lipids. To assess the impact of chlamydial in-
fection on LDs, we compared the neutral lipid content of
LDs isolated from infected and uninfected cells. Surpris-
ingly, infection with C. trachomatis markedly increased
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Lipid Droplet Markers Are Recruited to the
C. trachomatis Inclusion
(A and B) Accumulation of neutral lipids at
the chlamydial inclusion. HeLa cells were
infected with LGV L2 at an MOI of 0.5:1 for
20–24 hr. Infected cells were fixed in 3%
formaldehyde/0.025% glutaraldehyde and
stained with the neutral lipid dye BOD-
IPY493/503. (B) shows a higher magnification
of the cell boxed in (A). Note BODIPY 493/
503-positive reticular network enveloping
the inclusion (arrowheads). N, host nuclei.
*Uninfected cells.
(C) Chlamydial reticulate bodies accumulate
neutral lipids. LGV L2-infected HeLa cells
were fixed as above, permeabilized with
0.05% saponin, and incubated with BOD-
IPY493/503and anti-Chlamydiaantibodies (Ct).
(D) Subcellular localization of the LD marker
perilipin in infected cells. LGV L2-infected
HeLa cells were transfected with EGFP-peril-
ipin 7 hr postinfection, pulsed with 50 mM
oleic acid for 3 hr, and imaged at 24 hr. Note
localization of perilipin to classical Nile red
(NR)-positive LDs (arrows and inset) and to
reticular structures enveloping the chlamyd-
ial inclusion (arrowheads).
(E) Accumulation of cholesterol esters in LDs
ofC. trachomatis-infected cells. LDs were pu-
rified from cells infected with LGV L2 for 20
and 40 hr or with S. typhimurium (St) for 24
hr. Neutral lipids were extracted with diethyl
ether, separated on TLC plates, and detected
by fluorimetry after primuline staining.levels of cholesteryl esters (CE) recovered from LD frac-
tions (Figure 1E), suggesting that these organelles may
expand during infection. This increase in LD yield does
not constitute a generalized response to bacterial infec-
tion, since this increase in neutral lipids was not ob-
served in cells infected with the intracellular pathogen
Salmonella typhimurium (Figure 1F). To independently
assess whether lipid homeostasis was disrupted in in-
fected cells, we monitored the subcellular fractionation
of Nsdhl, a sterol biosynthetic enzyme that relocalizes
from the ER to LDs in response to increased levels of
cellular lipids [12]. Nsdhl recovery in LD fractions in-
creased during chlamydial infection, and this accumula-
tion was inhibited by the bacterial protein synthesis
inhibitor chloramphenicol (Figure S4). Overall, our re-
sults indicate that LD-like structures accumulate at the
periphery of the inclusion and that C. trachomatis alters
neutral lipid homeostasis.
Identification of Chlamydial LD-Associated Proteins
We predicted that C. trachomatis exported proteins into
the host cell to target LDs. To identify these proteins, we
screened a collection of yeast strains expressing GFP-
taggedChlamydia-specific ORFs [8] for proteins that co-
localized with an RFP-tagged LD protein (Erg6p). This
screen revealed four Chlamydia-specific ORFs (CT156,
CT163, CT257, and CT473) with marked tropism for yeast
LDs (Figures 2A and 2B). We focused our analysis on
three of these LD-associated chlamydial proteins.
Lda1 (CT156) and Lda2 (CT163) have no known func-
tional homologs, while Lda3 (CT473) displays limited ho-
mology to putative hemolysins. The lda1 and lda2 genesmap to a region of high genetic diversity within the C.
trachomatis chromosome that is termed the ‘‘plasticity
zone’’ (PZ). The PZ encodes several proteins that ex-
pand the pathogenic properties of C. trachomatis, in-
cluding ADP-ribosylating toxins, enzymes for the bio-
synthesis of tryptophan, and a family of phospholipase
D (PLD)-like proteins [13]. Lda1 has been postulated
to be a regulator of these PLD-like proteins [14].
Interestingly, PLD activity is necessary for the genera-
tion of LDs in cell-free systems [15], suggesting that
Lda1 and chlamydial PLD-like proteins may participate
directly in LD biogenesis. However, because Lda1 and
Lda2 are only found in C. trachomatis, this chlamydial
species may have specifically adapted to exploit intra-
cellular neutral lipid stores.
To test if the tropism of Lda proteins for LDs was con-
served in mammalian cells, HeLa cells were transfected
with vectors expressing EGFP-tagged forms of Lda1,
Lda2, and Lda3. Lda1 and Lda3 localized to ring-like
structures that stained with Nile red, indicating that
these proteins associated with mammalian LDs (Fig-
ure 2C). In contrast, Lda2-EGFP-expressing cells dis-
played low levels of cytoplasmic fluorescence with no
apparent association with LDs (data not shown). We
raised antibodies to synthetic peptides derived from
the predicted amino acid sequences of Lda1 and Lda3
and determined by immunofluorescence (IF) micros-
copy that these proteins are translocated into the host
cell and localize to structures adjacent to the
cytoplasmic face of the IM (Figure 3A). Consistent with
the described sensitivity of LD-associated proteins to
detergent permeabilization [16], the localization of Lda1,
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Associated Proteins
(A) Identification of Lda proteins by subcellu-
lar localization screens in yeast. Chlamydial
LD-tropic proteins were identified in yeast
by screening an expression library [8] for
GFP-tagged bacterial proteins that colocal-
ized with an RFP-tagged form of the yeast
LD protein Erg6p. Tropism of CT163-GFP to
cytoplasmic LDs (arrows) was readily appar-
ent by DIC microscopy and by colocalization
with Erg6-RFP.
(B) Biochemical fractionation of chlamydial
LD-tropic proteins expressed in yeast. LDs
were purified from yeast strains expressing
GFP or GFP-tagged forms of chlamydial
LD-associated proteins (Lda1/CT156, Lda2/
CT163, Lda4/CT257, and Lda3/CT473). The
distribution of these chlamydial proteins
was assessed in total lysates (T), vacuolar
fractions (V), and purified LDs (LD) by immu-
noblot analysis. The purity of fractions was
confirmed by monitoring the fractionation
of vacuolar (Vma1p), LD (Erg6p), and ER
(Sec12p) proteins.
(C) Ectopically expressed Lda proteins local-
ize to mammalian LDs. HeLa cells were trans-
fected with EGFP-tagged forms of Lda1 and
Lda3 and stained with Nile red (NR). Note
NR-positive ring-like structures enveloped
by Lda proteins (right panels).and to a lesser extent Lda3, was sensitive to solubi-
lization with 0.1% Triton X-100 (Figure 3B and data
not shown). Furthermore, Lda1 and BODIPY 493/503-
labeled structures partially overlapped at the inclusion
periphery (Figure 3C). These results strongly suggest
that C. trachomatis translocates proteins into the host
cytoplasm to target LD-like structures enveloping the
inclusion.
LDs Are Required for Lda2 Stability and for
Chlamydial Replication
Lda2 and Lda3 were independently identified in a screen
for chlamydial proteins that induce cytotoxic effects in
yeast [8]. To determine if the cytotoxicity of these pro-
teins is linked to LDs, we assessed if yeast mutants lack-
ing the triacylglycerol synthases and sterol acyltrans-
ferases required for LD generation [17, 18] were
resistant to Lda-mediated cytotoxicity. Interestingly,
disruption of all neutral lipid biosynthesis in lro1 dga1
are1 are2 mutants suppressed Lda2, but not Lda3, tox-
icity (Figure 4A). Because Lda2 was rapidly degraded in
these LD-deficient mutants (Figure 4B), the stability, and
by extension the function, of Lda2 is likely linked to LD
binding or to a function performed by LDs. We mapped
the minimal LD binding domain (Lda2LD) of Lda2 to aa
1–99 and determined that this domain is essential for
protein stability (data not shown). We hypothesize that
Lda2 did not appear tropic for LDs when ectopically ex-
pressed in HeLa cells in our earlier experiments because
degradation signals encoded at the carboxyl terminus ofLda2, combined with the low levels of LDs in epithelial
cells, make this protein inherently unstable. In contrast,
an Lda2LD-EGFP chimera was stable and prominently
localized to HeLa LDs (Figure 4C). Thus, as with Lda1
and Lda3, the LD binding properties of Lda2 are con-
served from yeast to mammals.
We raised antibodies against Lda2 and determined its
subcellular localization in infected cells. Like Lda1 and
Lda3, Lda2 localized to structures enveloping the inclu-
sion, and its detection by IF was detergent sensitive
(Figure 4D and data not shown). To determine if translo-
cated Lda2 associated with LDs, we purified LDs from
infected and uninfected cells and detected Lda2 by im-
munoblots. A protein of Lda2 predicted size (w64 kDa)
was detected only in LD fractions from infected cells
(Figure 4E). These findings lead us to conclude that C.
trachomatis secretes at least three proteins into the
host cells to target LD-like structures enveloping the
bacterial inclusion. Interestingly, Lda proteins ectopi-
cally expressed in infected cells also localize to the in-
clusion periphery (Figure S5), suggesting that these
proteins, while capable of localizing to classical LDs,
also bind to neutral-lipid-rich structures enveloping the
inclusion.
Because our results suggested a role for LDs in chla-
mydial infection, we tested if these organelles were re-
quired for bacterial replication. The inhibitor triacsin C
prevents LD formation by specifically inhibiting the ac-
tivity of a subset of long chain acyl-coA synthetases
(ACSL) required for triacylglyceride and cholesterol
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(A) Immunolocalization of Lda1 and Lda3. LGV-L2-infected cells were immunostained with antibodies specific to Lda1 and Lda3. Bacterial and
host DNA was detected by staining with Hoechst 33352 (blue). Lda1 and Lda3 (green) were found predominantly in close association with the
inclusion (arrowheads). Deconvolution microscopy of LGV-L2-infected cells labeled with anti-Lda and anti-IncG antibodies indicated that Lda1
and Lda3 localized to structures adjacent but distinct from the IM (right panels).
(B) Lda1 localization to the inclusion periphery is sensitive to detergent permeabilization. LGV-L2-infected HeLa cells were fixed and permea-
bilized with 0.05% saponin or 0.1% Triton X-100 and immunostained with anti-Lda1 and -IncG antibodies. The percentage of Lda1-positive
IncG-stained inclusions (n = 150) was measured. The pixel intensity of Lda1 staining around the inclusion is represented as the average of three
independent experiments with standard errors shown.
(C) Lda1 colocalizes with neutral-lipid-rich structures enveloping the inclusion. HeLa cells were infected, labeled with BODIPY 493/503, and
stained with anti-Lda1 antibodies. Note partial colocalization between Lda1- and BODIPY-positive structures (inset).ester biosynthesis [19]. We examined the effect of triac-
sin C in cells infected withC. trachomatis (Figure 4F) and
determined that this inhibitor greatly reduced chlamyd-
ial proliferation and this effect was comparable to that
of AACOCF3, a cPLA2 inhibitor that blocks chlamydial
phospholipid uptake [5]. In triacsin C-treated cells, in-
clusions were small and misshapen, although expres-
sion of IncG, which is expressed shortly after chlamydial
entry, indicated that the block in chlamydial replication
occurred postinvasion (Figure S6).
Interestingly, triacsin C inhibited chlamydial growth in
Hep2 cells 20 6 1.5-fold more potently than S. typhimu-
rium (Figure 4F, inset), suggesting that this inhibitor is
not causing a general cellular lipid imbalance that would
nonspecifically limit replication of intracellular bacteria.
Although we cannot presently exclude the possibility
of a nonspecific effect of triacsin on chlamydial metabo-
lism, the absence of an ACSL homolog inC. trachomatis
and the high in vivo specificity of triacsin C for specificsubclasses of highly related mammalian ACSLs render
it unlikely that the impact of triacsin C on chlamydial
growth is due to the inhibition of a bacterial enzyme.
LD Function and Chlamydial Biology
Why doesC. trachomatis target LDs? The simplest inter-
pretation is that LDs act as conduits for the transport of
neutral lipids to the inclusion. More complex possibili-
ties are suggested by recent proteomic analysis of
LDs, which revealed that mammalian LDs are enriched
for proteins associated with vesicular transport (e.g.,
Rab proteins), signaling, and the cytoskeleton [20–22].
The presence of these proteins in LDs challenges the
notion that these organelles are passive lipid storage
depots and raises the intriguing possibility that LDs
may regulate cellular functions ranging from signaling
to membrane transport [1]. Therefore, by harnessing LD
functions C. trachomatis may also co-opt non-vesicle-
mediated phospholipids and cholesterol transport [23],
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synthesis Is Required for Chlamydial Replication
(A) Lda2 cytotoxicity in yeast is suppressed in mutants lacking LDs.
Ten-fold serial dilutions of wild-type (WT) or LD-deficient (LD2)
yeast strains expressing Lda2 or Lda3 under the control of the
GAL1 promoter were spotted on 2% galactose plates to assess
Lda-dependent toxicity.
(B) Lda2 is unstable in the absence of LDs. Lda2 stability in wild-type
and LD-deficient yeast strains was determined by expressing Lda2
for 7 hr in CSM-Uracil + 0.5% galactose, followed by replacing the
media with CSM-Uracil + 2% dextrose (‘‘Dex Chase’’). Levels of
Lda2 proteins were assessed by Western blots using anti-Lda2
antibodies.
(C) The N terminus of Lda2 mediates LD binding. Amino acids 1–99
of Lda2 (Lda2LD) containing the minimum LD binding domain were
fused to EGFP and expressed in HeLa cells. Lda2LD localized to
NR-positive LDs (arrows).
(D) Lda2 localizes to the periphery of the chlamydial inclusion. In-
fected HeLa cells were fixed, permeabilized with 0.05% saponin,
and immunostained with anti-Lda2-specific antibodies. Arrows in
corresponding DIC images show localization of inclusions.
(E) Lda2 is enriched in LD fractions from infected cells. LDs were
isolated from infected cells, normalized to protein content, and re-
solved by SDS PAGE. Immunoblots with anti-Lda2 antibodies
show a single immunoreactive band specifically enriched in LDs
from infected cells. Nsdhl is shown as a LD fractionation control.
*Crossreactive bands.
(F) Host neutral lipid biosynthesis is required for C. trachomatis rep-
lication. Hep2 cells were infected with LGV L2 in the presence of
the indicated concentrations of triacsin C or the cPLA2 inhibitor
AACOCF3 for 40 hr. Bacterial replication was assessed by themembrane dynamics, and/or lipid-mediated signaling
pathways. Alternatively, the proliferation of LDs at the
chlamydial inclusion may constitute an example of
‘‘organelle mimicry,’’ whereby the inclusion is cloaked
in LD-like structures and thus excluded from fusion
with degradative compartments.
In summary, our observations indicate that LD-like
structures accumulate at the chlamydial inclusion, and
at least three LD-tropic chlamydial proteins are secreted
across the IM. Furthermore, LDs are required for Lda2
stability, and inhibition of neutral lipid biosynthesis im-
pairs chlamydial replication. These results strongly sug-
gest that C. trachomatis targets LDs as a pathogenic
strategy. These findings provide a unique opportunity
to explore the function of these understudied organelles
and unravel the molecular mechanisms of organelle
subversion by Chlamydiae.
Experimental Procedures
Cell Lines, Yeast Strains, Reagents, and Antibodies
Hep2 and HeLa cells were obtained from ATCC. Yeast growth con-
ditions and screens for Lda proteins are described in the Supple-
mental Data. For Lda suppression analysis, the congenic yeast
strains G175 (MATa ADE2 his3 leu2 ura3 trp1) and H1246 (MATa
ADE2 ura3 dga1::KanMX4 lro1::TRP1 are1::HIS3 are2::LEU2) [24]
were used. Triacsin C, AACOCF3, and nocodazole were purchased
from Biomol International L.P., (PA), Calbiochem (CA), and Sigma-
Aldrich (MO), respectively. Antibodies against synthetic peptides
derived from Lda1 (RNTNRENREFHHHDQDRT) and Lda3 (ES-
PDDRTVPHTQETS) were generated in hens (Aves Labs Inc., OR).
Antibodies against GST-Lda2 were generated in rabbits (Covance
Immunology Services, PA). The specificity of anti-Lda antibodies
was tested against recombinant proteins expressed in yeast.
Additional antibodies and methods used are described in the
Supplemental Data.
Microscopy
Images were acquired with a Leica TCS SL confocal microscope and
a Zeiss Axioskop 2 mot plus epifluorescence microscope equipped
with an ORCA ER Hamamatsu CCD camera. Detailed IF methods are
described in the Supplemental Data.
LD Analysis
LDs were isolated from yeast cells as described earlier [25]. LDs
were isolated from infected and uninfected Hep2 cells by a modifica-
tion of previously described protocol [22]. Briefly, cells were washed
with PBS and harvested by scraping in TNE (20 mM Tris.Cl [pH 8.0],
120 mM NaCl, 2 mM EDTA) containing a protease inhibitor cocktail
(Roche Diagnostics, Germany). The cells were lysed on ice with
a Dounce homogenizer, and cell lysates were adjusted to 0.45 M
sucrose. The lysate was overlaid with 2 ml each of 0.25 M, 0.15 M,
and 0 M sucrose/TNE and centrifuged at 30,000 rpm for 90 min in
a SW41 rotor (Beckman Coulter Inc., CA). The floating lipid layer
was collected and centrifuged at 45,000 rpm for 45 min in a TLA55
rotor on a tabletop ultracentrifuge (Beckman Coulter, CA). For
protein analysis, pure LDs were delipidated twice with 10 volumes
of diethylether, and the proteins were precipitated from the aqueous
layer with ice-cold acetone and dried before dissolving in 0.1% SDS/
0.1 N NaOH. For neutral lipid analysis, lipids were extracted from
generation of infectious units as outlined in the Supplemental
Data. Inset: Growth inhibition of S. typhimurium (St) and LGV L2
(Ct) in triacsin-treated cells represented as a percent growth in
untreated cells.
Chlamydial growth in the presence of indicated inhibitors was mea-
sured as described in the Supplemental Data. Values shown are an
average of three independent experiments with standard error
shown.
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1651LDs with diethylether and dried under a stream of N2. Lipids were re-
dissolved in a small volume of ether and analyzed by thin-layer chro-
matography on glass-backed HPTLC silica plates (Merck, USA).
Neutral lipids were separated in a solvent mix of 70:30:1 v/v/v (hex-
ane: diethylether: acetic acid) and stained with 0.1% primuline
(Sigma). Fluorescence was captured on a Typhoon laser scanner
(GE Healthcare).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures and six figures and can be found with this article online at
http://www.current-biology.com/cgi/content/full/16/16/1646/DC1/.
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